Revealed: Secret of HIV's natural born killers

Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

In a study they said holds promise for an , researchers from four countries reported the secret lies not in the number of infection-killing cells a person has, but in how well they work.

Only about one person in 300 has the ability to control the (HIV) without drugs, using a strain of "killer" cells called cytotoxic T lymphocyte (CTL) cells, previous research has found.

Taking that discovery further, scientists from the United States, Canada, Japan and Germany reported that the strain has molecules called receptors that are better able to identify HIV-infected for attack.

Until now, it was well known that people with HIV "have tonnes of these ," Bruce Walker, an infectious diseases expert at the Ragon Institute in Massachusetts, told AFP.

"We have been scratching our heads since then, asking how, with so many killer cells around, people are getting AIDS. It turns out there is a special quality that makes them (some cells) better at killing."

The study looked at 10 infected people, of whom five took to keep HIV under control while five were so-called elite controllers who remained naturally healthy.

HIV kills a type of white blood cell called CD4, leaving people with AIDS wide open to other, opportunistic and potentially .

"What we found was that the way the killer cells are able to see infected cells and engage them was different," said Walker.

"It is not just that you need a killer cell, what you need is a killer cell with a (T cell) receptor that is particularly good at recognising the infected cell. This gives us a way to understand what it is that makes a really good killer cell."

Walker said attempts at creating vaccines had so far failed because the T they generated were not the efficient type.

But while the research has showed scientists how to find and measure the good cells, they still do not yet know how to generate them.

"The next step is to determine what it is about those receptors that is endowing them with that ability," said Walker.

"HIV has revealed another one of its secrets and that is how the body is able to effectively control the virus in certain individuals.

"Each secret that HIV reveals is putting us in a better position to ultimately make a vaccine to control the virus."

More information: Nature Immunology, DOI: 10.1038/ni.2342

add to favorites email to friend print save as pdf

Related Stories

Exhausted B cells fail to fight HIV

Jul 14, 2008

HIV tires out the cells that produce virus-fighting proteins known as antibodies, according to a human study that will be published online July 14 in the Journal of Experimental Medicine.

Recommended for you

More otologic symptoms, hearing loss for HIV-infected

7 hours ago

(HealthDay)—Otologic symptoms and hearing loss are more common among patients with HIV than uninfected controls, according to a study published online March 5 in JAMA Otolaryngology—Head & Neck Surgery.

Preventing one case of HIV saves over $225K, study shows

Feb 27, 2015

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, answer ...

Research captures transient details of HIV genome packaging

Feb 27, 2015

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

baudrunner
not rated yet Jun 11, 2012
CD4 is a receptor site on a host cell. HIV needs two receptor sites to allow for entry into a host cell. The other is CCR5. In one percent of the population, the allele responsible for expressing CCR5 is mutant and non-functioning, therefore HIV replication cannot occur and the body's natural defenses rid the bloodstream of the virus. Pfizer has developed a CCR5 blocker that may be the best line of offense against progression of the disease, and to my knowledge it is currently undergoing clinical trial, a long and tedious process that normally takes years. Prepare for an anouncement sooner than later.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.